Surgical outcome of patients with thoracic esophageal cancer positive for cervical lymph nodes

Hepato-Gastroenterology

Volumn 54, Issue 73, 2007, Pages 100-103

  Shimada, Hideaki ^a   Shiratori, Tooru ^a   Okazumi, Shin Ichi ^a   Matsubara, Hisahiro ^a   Nabeya, Yoshihiro ^a   Shuto, Kiyohiko ^a   Shimizu, Takanori ^a   Hayashi, Hideki ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cervical lymph node; Esophageal cancer; Prognosis; Squamous cell carcinoma; Three field lymph node dissection

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; UNIVARIATE ANALYSIS;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 34047176341     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sobin LH, Wittekind Ch: TNM Classification of Malignant Tumours. Sixth Edition 2002; pp. 60-64.
2. Isono K, Ochiai T, Okuyama K, Onoda S: The treatment of lymph node metastasis esophageal cancer by extensive lymphadenectomy. Jpn J Surg 1990; 20:151-157.
3. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y: Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220:364-373.
4. Tachibana M, Kinugasa S, Yoshimura H, et al: Clinical outcome of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005; 189:98-109.
5. Shiozaki H, Yano M, Tsujinaka T, et al: Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esoph 2001; 14:191-196.
6. Tabira Y, Okuma T, Kondo K, Kitamura N: Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 1999; 117:239-245.
7. Bhansali MS, Fujita H, Kakegawa T, et al: Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997; 21:275-281.
8. Nakagawa S, Kanda T, Kosugi S, et al: Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004; 198:205-211.
9. Iizuka T, Ide H, Kakegawa T, et al: Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 1988; 93:1054-1058.
10. Japanese Esophageal Oncology Group: A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 1993; 104:203-207.
11. Ando N, Iizuka T, Kakegawa T, et al: A randomized trial of surgery with and without chemotherapy for localized squamous cell carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thoraci Cardiovasc Surg 1997; 114:205-209.
12. Ando N, Iizuka T, Ide H, et al: Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 24:4592-4596.
13. Ando N, Ozawa S, Kitagawa Y, et al: Improvement in the results of surgical treatment of advanced squamous cell esophageal carcinoma during 15 consecutive years. Ann Surg 2000; 232:225-232.
14. Baba M, Aikou T, Yoshinaka H, et al: Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994; 219:310-316.
15. Altorki N, Kent M, Ferrara C, Port J: Three-field lymph node dissection for squamous cell and adenocarcinoa of the esophagus. Ann Surg, 2002; 236:177-183.
16. Shimada H, Kitabayashi H, Nabeya Y, et al: Treatment response and prognosis of patients after recurrence of esophageal cancer. Surg 2003; 133:24-31.
17. Igaki H, Kato H, Tachimori Y, Tachimori Y, Naknishi Y: Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery 2003; 133:368-374.